共 12 条
[1]
Serpin-resistant mutants of human tissue-type plasminogen activator. Madison E L,Goldsmith E J,Gerard R D et al. Nature . 1989
[2]
Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Otter M,Van Berkel T J C,Rijken D C et al. Thrombosis and Haemostasis . 1989
[3]
Nelles L et al Biochemical and biologic properties of rt-PA del (K296~G302) , a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1. Li X K,Lijnen H R. Blood . 1992
[4]
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Madison E L,Goldsmith E J,Gerard R D et al. Proceedings of the National Academy of Sciences of the United States of America . 1990
[5]
Tissue plasminogen activator is endocytosed by mannose and galactose receptorof rat liver cells. Smedsrod B,Einarsson M,Pertoft H et al. Thrombosis and Haemostasis . 1988
[6]
Determination of tissue plasminogen activator and its fast inhibitor in plasma. Chmielewska J,Wiman B. Clinical Chemistry . 1986
[7]
Molecular cloning, A laboratory manual. Sambrook J,Fritch E F,Maniatis T. . 1989
[8]
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Chmielewska J,Ranby M,Wiman B. Thrombosis Research . 1983
[9]
In vivo interaction of tissue-type plasminogen activator with liver cells. Kuiper J,Otter M,Rijken D C et al. Journal of Biological Chemistry . 1988
[10]
Fibrin plate method for estimating fibrinolytic activity. Astrup T,Muellertz S. Archive of Biochemistry and Biophysics . 1952